Deborah Morosini, EVP, Chief of Clinical Affairs at Prelude Therapeutics Inc (PRLD), sold 57,102 shares at $15.87 ($906K) on 2021-11-16, disclosed to the SEC on 2021-11-18.
Open-market sale of $906k PRLD by EVP, Chief of Clinical Affairs. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.87 | 28,351 | $450K | 49.6% |
| 2 | $15.87 | 28,351 | $450K | 49.6% |
| 3 | $16.43 | 400 | $7K | 0.7% |
| Total | $15.87 avg | 57,102 | $906K | 100% |
| Filing → |
| PRLD | SELL | 2021-04-15 | $4K | — | Filing → |
| PRLD | SELL | 2021-04-09 | $40K | — | Filing → |
| PRLD | BUY | 2020-09-29 | $8K | — | Filing → |